Konstantinos Rounis

Karolinska University Hospital

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Immunology Immunology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Sofia Agelaki

Professor of Medical Oncology

University of Crete

GREECE

View details

Alfonso Martín-Bernabé

Karolinska Institutet

SWEDEN

View details

Johan Botling

Associate professor

Uppsala University

SWEDEN

View details

Pablo Moreno

Head of DSP

SPAIN

View details

Simon Ekman

Professor, Senior Consultant

Karolinska University Hospital

SWEDEN

View details

Nikolaos Galanakis

Assistant Professor of Interventional Radiology

University of Crete

GREECE

View details

Patrick Micke

Professor

Uppsala University

SWEDEN

View details

Antti Ylipää

Chief Executive Officer

FINLAND

View details

CHARA PAPADAKI

University of Crete

GREECE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Konstantinos Rounis

Research Interests

Explore related searches

Contact this professor

Articles (10)

Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies

Complications following novel therapies for non‐small cell lung cancer

Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab

High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC

A Prognostic Role for Circulating microRNAs Involved in Macrophage Polarization in Advanced Non-Small Cell Lung Cancer

Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study

Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study

MicroRNAs Regulating Tumor and Immune Cell Interactions in the Prediction of Relapse in Early Stage Breast Cancer

Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy

Collaborators (9)

Sofia Agelaki

Alfonso Martín-Bernabé

Johan Botling

Pablo Moreno

Simon Ekman

Nikolaos Galanakis

Patrick Micke

Antti Ylipää

CHARA PAPADAKI

Make your next move.